This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Miyoshi Myopathy
Information about Miyoshi Myopathy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Miyoshi Myopathy
Most recent studies have shown that Miyoshi Myopathy shares some biological mechanisms with abnormal-degeneration, atrophy, distal-muscular-dystrophies, dystrophy, inflammation, leyden-moebius-muscular-dystrophy, muscle-degeneration, muscle-weakness, muscular-atrophy, muscular-dystrophies-limb-girdle, muscular-dystrophy, muscular-dystrophy-duchenne, myopathy, myositis, neuromuscular-diseases, polymyositis, sarcoglycanopathies, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Miyoshi Myopathy, and have been seen in publications frequently: Cell Activation, Endocytic Recycling, Endocytosis, Fertilization, Inflammatory Response, Localization, Membrane Fusion, Muscle Atrophy, Muscle Hypertrophy, Myoblast Fusion, Pathogenesis, Phagocytosis, Plasma Membrane Repair, Proteolysis, Regeneration, Response To Lipopolysaccharide, Spermatogenesis, Translation, Transport, Vesicle Fusion
Quite a number of genes have been found to play important roles in Miyoshi Myopathy, such as ANO5, ANXA2, CAPN3, CAV3, CHKA, CHKB, DAG1, DCTN1, DMD, DMPK, DYSF, FKTN, IRF1, MYOF, OTOF, PARVB, SGCA, TCAP, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.